Results of the SPACE trial demonstrating the safety and efficacy of subcutaneous fremanezumab for the prevention of pediatric ...
Israeli pharma and generics player Teva (NYSE: TEVA), says the New England Journal of Medicine has published Phase III data ...
AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback